Blood clotting tests before and after surgery for cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how cancer and surgery affect blood clotting. It may help doctors understand and prevent blood clots in patients having surgery for certain cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been newly diagnosed with cancer of the liver, pancreas, bile ducts, esophagus, colon, rectum, or lung, or cancer that has spread to the liver
- You are planning to have surgery to remove the cancer
- You are not pregnant
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
This study is testing a new blood test that looks for leftover cancer cells after surgery. It is for people with different types of solid tumors who are planning to have surgery to cure their cancer. The goal is to see if the test can help guide future treatment decisions.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
This study looks at how blood clotting problems affect people with cancer. It tests whether certain cancers or severe infections cause changes in the body's ability to break down blood clots.
This trial looks at using a blood-clotting test called TEG during certain surgeries in children where bleeding is likely. The goal is to see whether this test helps doctors better manage transfusions (blood or blood products) during and after the operation.
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.